An important paraplegia case due to synthetic cannabinoid bonsai abuse
暂无分享,去创建一个
H. Tekeli | H. Şimşek | S. Demir | A. Eroğlu | E. Karagoz | M. Senol | Rifat Erdem Tugrul
[1] M. Farré,et al. Emerging drugs in Europe , 2014, Current opinion in psychiatry.
[2] W. Fantegrossi,et al. Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity? , 2014, Life sciences.
[3] M. Aşırdizer,et al. Review of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine, Turkey. , 2013, Journal of forensic and legal medicine.
[4] V. Auwärter,et al. Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings. , 2013, Addiction.
[5] K. Heard,et al. A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010. , 2012, Annals of emergency medicine.
[6] R. Mahieux,et al. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects. , 2012, Revue neurologique.
[7] M. Forrester,et al. Synthetic Cannabinoid Exposures Reported to Texas Poison Centers , 2011, Journal of addictive diseases.
[8] G. Edwards. Addiction research centres and the nurturing of creativity. , 2009, Addiction.
[9] J. Singh,et al. Therapeutic potential of cannabinoid receptor ligands: current status. , 2006, Methods and Findings in Experimental and Clinical Pharmacology.
[10] R. Vandrey,et al. A survey study to characterize use of Spice products (synthetic cannabinoids). , 2012, Drug and alcohol dependence.
[11] R. Pertwee,et al. Pharmacological actions of cannabinoids. , 2005, Handbook of experimental pharmacology.